These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23431016)

  • 1. Blocking the entrance to open the gate.
    Schrauwen P; Timmers S; Hesselink MK
    Diabetes; 2013 Mar; 62(3):703-5. PubMed ID: 23431016
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.
    Keung W; Ussher JR; Jaswal JS; Raubenheimer M; Lam VH; Wagg CS; Lopaschuk GD
    Diabetes; 2013 Mar; 62(3):711-20. PubMed ID: 23139350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.
    Vavrova E; Lenoir V; Alves-Guerra MC; Denis RG; Castel J; Esnous C; Dyck JR; Luquet S; Metzger D; Bouillaud F; Prip-Buus C
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E649-60. PubMed ID: 27507552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
    Shi Y; Burn P
    Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipase Inhibitors for Obesity: A Review.
    Liu TT; Liu XT; Chen QX; Shi Y
    Biomed Pharmacother; 2020 Aug; 128():110314. PubMed ID: 32485574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
    Sasaoka T; Wada T; Tsuneki H
    Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Promises of Chlorogenic Acid with Special Emphasis on its Anti-Obesity Property.
    Kumar R; Sharma A; Iqbal MS; Srivastava JK
    Curr Mol Pharmacol; 2020; 13(1):7-16. PubMed ID: 31333144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
    Ceccarelli SM; Chomienne O; Gubler M; Arduini A
    J Med Chem; 2011 May; 54(9):3109-52. PubMed ID: 21504156
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors.
    Declercq PE; Falck JR; Kuwajima M; Tyminski H; Foster DW; McGarry JD
    J Biol Chem; 1987 Jul; 262(20):9812-21. PubMed ID: 3597441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic investigation of carnitine palmitoyltransferases in homogenates of human skeletal muscle using L-amino-carnitine and malonyl-CoA.
    Hertel K; Gellerich FN; Hein W; Zierz S
    Adv Exp Med Biol; 1999; 466():87-93. PubMed ID: 10709631
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular insight and pharmacological approaches targeting mitochondrial dynamics in skeletal muscle during obesity.
    Jheng HF; Huang SH; Kuo HM; Hughes MW; Tsai YS
    Ann N Y Acad Sci; 2015 Sep; 1350():82-94. PubMed ID: 26301786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminocarnitine ureidic derivatives as inhibitors of carnitine palmitoyltransferase I.
    Tassoni E; Conti R; Gallo G; Vincenti S; Dell'Uomo N; Mastrofrancesco L; Ricciolini R; Cabri W; Carminati P; Giannessi F
    ChemMedChem; 2010 May; 5(5):666-9. PubMed ID: 20232438
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats.
    Dobbins RL; Szczepaniak LS; Bentley B; Esser V; Myhill J; McGarry JD
    Diabetes; 2001 Jan; 50(1):123-30. PubMed ID: 11147777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity.
    Kuhajda FP; Ronnett GV
    Curr Opin Investig Drugs; 2007 Apr; 8(4):312-7. PubMed ID: 17458181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership.
    McGarry JD
    Biochem Soc Trans; 1995 Aug; 23(3):481-5. PubMed ID: 8566378
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of acetyl-L-carnitine and oxfenicine on aorta stiffness in diabetic rats.
    Chang KC; Tseng CD; Lu SC; Liang JT; Wu MS; Tsai MS; Hsu KL
    Eur J Clin Invest; 2010 Nov; 40(11):1002-10. PubMed ID: 20678118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of pancreatic lipase.
    Blackburn GL
    Am J Clin Nutr; 2000 Mar; 71(3):845-6. PubMed ID: 10702184
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural products in anti-obesity therapy.
    Vermaak I; Viljoen AM; Hamman JH
    Nat Prod Rep; 2011 Sep; 28(9):1493-533. PubMed ID: 21738930
    [No Abstract]   [Full Text] [Related]  

  • 19. More about orlistat.
    Lucas KH; Kaplan-Machlis B
    Pharmacotherapy; 2000 Jul; 20(7):872-3. PubMed ID: 10907983
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting hyperglycaemia with anti-obesity drugs: time for a paradigm shift?
    Krentz AJ; Hompesch M
    Drugs; 2013 Oct; 73(15):1649-51. PubMed ID: 24092613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.